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Executive Summary
Despite the progress made in reducing fertility and increasing the contraceptive prevalence rate
(CPR) in Kenya, many women still experience a high unmet need for contraception. Part of the
challenge in addressing current levels of unmet need is the limited use of contraception by women
during the first 12 months postpartum. New methods are needed that offer greater ease of use, that
are women-initiated, and that do not require significant health infrastructure or medical provider
involvement for service delivery. One such method is the Progesterone Vaginal Ring (PVR), a userinitiated, reversible contraceptive that according to clinical trial data is safe and effective for
breastfeeding women.
New product introduction strategies often suffer from lack of available market research and rely on
hypothetical approaches to gauge consumer demand and provider readiness to offer services. The
PVR, a new product in sub-Saharan Africa, faced such a challenge. For this reason, we determined
that a study on Willingness to Pay (WTP) was necessary to estimate the effect of price on potential
consumer demand for the method in Kenya.
The specific objectives of the study were to: (1) assess the willingness to pay for the PVR among
potential users (women seeking family planning services at health facilities); (2) assess the
willingness among health care providers (in public, private nonprofit, and private commercial
sectors) to counsel on and offer the PVR to users; and (3) assess the willingness to procure the PVR
among potential suppliers, including the government and donors. The study was conducted in
Nairobi County between March and June 2015. The following are the main findings:


Women seeking family planning services at public, private nonprofit, and private commercial
facilities are willing to pay for the PVR if it is available. A significant proportion of women who
visit the private commercial sector spend 50–199 Kenya shillings (KES) (US$0.5–$2) per
month on family planning (FP) services and products. This implies that a market currently
exists for family planning products through the private commercial sector.



The majority of respondents were willing to pay a price equivalent to a three-month supply of
Progestogen-only pills (POP) plus a 10% increment on that price, with some variation across
sectors. Respondents from public sector facilities were more sensitive to marginal price
increments than those who were interviewed at private sector facilities.



Nearly universally, health care providers (based in public, private nonprofit, and private
commercial facilities) indicated that the PVR is an important option to include in the choice
of methods, especially in light of the frequent and prolonged stock-out of Microlut
contraceptive pills. They are willing to counsel and provide the PVR to users. Providers in the
public and private nonprofit sectors suggested a median price of KES100 (US$1) and those
in the private commercial sector proposed a median price of KES200 (US$2).



Procurers are willing to procure the PVR and make it available through their distribution
networks and outlets. They are willing to purchase the PVR at a much higher cost than what
consumers had proposed.
1



There is potential for the private sector to play an active role in FP provision for the
introduction of the PVR by serving customer segments based on their level of willingness to
pay. Social marketing organizations and commercial players can ease the burden on public
health expenditure while tapping into Kenya’s growing economy, bringing consumers who
have varying levels of ability to pay for FP products and services.

All key stakeholders (i.e., women, providers, and procurers in public, private nonprofit, and private
commercial sectors) were interested and supportive of the one-year ring. All the individuals
interviewed were willing to pay for the long-acting ring at higher costs than the PVR. The median
price for the one-year ring varied across the sectors—KES100 (US$1) in the public sector, KES400
(US$4) in the private nonprofit sector, and KES500 (US$5) in the private commercial sector. The
study determines the ability of public sector consumers to afford FP products and the potential for
serving them via private sector mechanisms.
In terms of utilization, the results generated will inform and guide the next steps about product
introduction. Specifically, the findings of this study will be integrated with results from a market
segmentation exercise conducted earlier to develop a pricing model for the PVR. The price will reflect
not only the cost of goods sold (COGS) and costs of product introduction (e.g., training, educational
material, marketing and branding, demand creation), but also the benefits to the health system (e.g.,
limited need for infrastructure and equipment, potential for multiple service outlets and health
cadres). The results will also be useful to refine PVR market segmentation and tailor specific
strategies for product introduction, including innovative financing approaches.
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Introduction
According to the Kenya Demographic and Health Survey (KDHS) 2014, Kenya’s total fertility rate (TFR) is
3.9 births per woman (3.1 urban and 4.5 rural). It is important to point out that the TFR has declined from
8.1 births per woman in the mid-1970s to the current level of 3.9 births. The contraceptive prevalence
rate (CPR) is usually defined as the percentage of currently married women using any contraceptive
method. Slightly more than half of currently married women (58%) are using some method of
contraception. Among currently married women, modern methods of contraception are more commonly
used (53%) than traditional methods (5%). Of the modern methods, injectables are the most widely used
(26%), followed by implants (10%) and the pill (8%). The calendar rhythm method is the most popular
traditional method used (4%).
Contraceptive prevalence increases dramatically with education. Near one-fifth (18%) of currently married
women with no education use a method, while more than half of women with at least some primaryschool level of education use contraception. Women with three to four children are the most likely to use
contraception (66%). Currently married women in the Central region have the highest CPR (73%), followed
by women in the Eastern region (70%). Contraceptive use is lowest in the North Eastern region (3%).
Table 1 provides information on family planning (FP) services (including sterilization) and how frequently
these are offered, by facility type and managing authority (Kenya Service Provision Assessment [KSPA]
2010).

TABLE 1 Background characteristics
Modern FP
Method
Offered (%)

Counseling on
Natural Method
Offered (%)

Temporary FP
Method Offered
(%)

Male or Female
Sterilization
Offered (%)

Male or Female Number of
Facilities
Sterilization
Provided (%)

Hospital

85

75

91

67

46

51

Health center

83

64

86

33

20

80

Maternity

88

63

88

47

31

17

Clinic

80

44

81

18

3

203

Dispensary

89

59

94

22

2

340

Government

96

64

97

33

11

344

NGO

89

36

89

24

7

22

Private
(for profit)

84

46

84

21

7

236

Faith-based
organization

44

58

69

12

3

88

Type of Facilities

Managing Authority
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Despite the progress made in reducing fertility and increasing the contraception use prevalence rate,
many women still experience a high unmet need for contraception. Part of the challenge in addressing
current levels of unmet need is the limited use of contraception by women during the first 12 months
postpartum, and the high discontinuation rates with about half of all users abandoning their methods
6 months after adoption. New methods are needed that offer greater ease of use, are women-initiated,
and do not require significant health infrastructure or medical provider involvement for service
delivery. One such method is the Progesterone Vaginal Ring (PVR), a user-initiated, reversible
contraceptive that, according to clinical trial data, is safe and effective for breastfeeding women.
The Progesterone Vaginal Ring (PVR) is designed exclusively for addressing the postpartum family
planning needs of breastfeeding women. While the PVR is already being used by women in nine
countries in Latin America, women in sub-Saharan Africa, where breastfeeding is almost universal,
have no access to this technology. To expand access in this region, the Population Council, with
funding from the Bill & Melinda Gates Foundation (BMGF) and the United States Agency for
International Development (USAID), conducted various pre-introductory activities in sub-Saharan Africa
where women practice prolonged lactation and also have a high unmet need for postpartum family
planning of up to 65% in many countries (Sonalkar et al. 2013). The assessment of “Willingness to
Pay” (WTP) for the PVR was conducted to understand the economic factors that may determine its
uptake and use. In the case of contraceptives, WTP informs about the value that people attach to the
benefits of various contraceptives, especially their willingness and intention to purchase them at
various assigned hypothetical prices.
Ever-increasing changes in the funding landscape have prompted governments to explore “total
market” solutions. The Total Market Approach (TMA) identifies specific roles for the public and private
sectors in meeting the FP needs of the population. Specifically, it focuses on ensuring that free or
subsidized contraceptives are available to the needy and poor, and social marketing channels and
other private commercial sales of contraceptives cater to those who are able to pay. This approach
can help ensure equity and sustainability of products and services over time and also manage funding
shortfalls. Using TMA as a guiding design principle, this study provides new knowledge on the
maximum amount of money that consumers are willing to pay for the PVR and a related ring, the oneyear contraceptive vaginal ring (CVR), from various service sectors (public, private nonprofit, and
private commercial).

Setting
COUNTRY ECONOMIC CONTEXT
According to the Kenya National Bureau of Statistics (KNBS 2015), Kenya’s economic growth was
4.9% in the first quarter of 2015 compared with 4.7% in the same period in 2014. Categorized as a
lower-middle-income country, with a population of close to 45 million people, Kenya is among the
promising emerging economies in East Africa. The business environment has significantly improved in
Kenya in recent years with investments in infrastructure, agriculture, manufacturing, and other
industries. The construction of a new railway line, initially to run from Mombasa to Nairobi, is
scheduled for completion in mid-2017. To achieve strong and sustainable economic growth and
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poverty reduction, the government is focusing on reducing the cost of doing business and encouraging
private sector innovation and entrepreneurship as well as business expansion.
The per capita household final consumption expenditure in Kenya (the market value of all goods and
services, including durable products such as cars, washing machines, and home computers purchased
by households) has been on an upward trend since 2014, reaching US$517,1 while the gross national
income per capita has risen steadily from US$1,040 in 2011 to US$1,290 (current US$). In 2013,
private health expenditure (% of GDP), which includes direct household (out-of-pocket) spending,
private insurance, and charitable donations by private corporations, was 2.6, staying the same since
2011. Public health expenditure2 (as % of GDP) was 1.9 in 2013 and has remained close to this level
since 2011. Total health expenditure3 (% of GDP) has risen slightly from 4.3 in 2011 to 4.5 in 2013.
Kenya’s Gross Domestic Product (GDP) is estimated at US$70 billion (2015 estimate) with an
estimated GDP per capita of US$1,588 (for 2015) at current prices.

TABLE 2 Cost of living snapshot in Nairobi, Kenya
Quantity

Average Price (US$)

Milk

Commodity

1 gallon

3.4

Bread

1 pound

0.5

Eggs

1 dozen

1.4

Onion

1 pound

0.4

Beef

1 pound

2.1

Gasoline

1 gallon

1.7

Source: www.numbeo.com.

The average annual Consumer Price Index (CPI) increased from 140.1 in 2013 to 149.7 in 2014.
This resulted in a modest increase in the rate of inflation and attributed to increases in the cost of
several food and nonfood items, which outweighed notable falls in the cost of electricity and
petroleum products including petrol, diesel, and kerosene. The inflation rate maintained its singledigit level, rising from 5.7% in 2013 to 6.9% in 2014.4 With its competitive manufacturing sector
driving new job creation and exports, Kenya is poised for successful economic growth.

COUNTRY FAMILY PLANNING FINANCING CONTEXT
In Kenya, the public and private sectors (including households) are the primary sources of
reproductive health (RH) financing.5 Funding shortages have encouraged exploration of innovative
financing models and coordinated action from the private sector, including social marketing
organizations. The role of the private sector is largely underutilized and the public sector continues
to take on a dominant role in providing FP products and services. The major sources of modern
1

Data reported in constant 2005 US dollars. Sources: World Bank national accounts data and OECD National Accounts data files.

2

4

Public health expenditure consists of recurrent and capital spending from government (central and local) budgets, external
borrowings and grants (including donations from international agencies and nongovernmental organizations), and social (or
compulsory) health insurance funds.
Total health expenditure is the sum of public and private health expenditure. It covers the provision of health services (preventive and
curative), family planning activities, nutrition activities, and emergency aid designated for health, but does not include provision of
water and sanitation.
Current World Bank data (2015).

5

Republic of Kenya (2011), Kenya National Health Accounts 2009/10.

3
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contraceptives for women are public health facilities (57%) and private health facilities (a
substantial 36%). Other sources, such as mobile clinics, community-based distribution, and shops,
comprise the remaining six percent (KNBS and ICF Macro 2010). Kenya’s FP market provides a
variety of methods—hormonal, intrauterine devices (IUDs), surgical, barrier, lactational
amenorrhea method (LAM), and fertility awareness (DRH and MOPHS 2010). Injectables, priced
slightly less than US$1 per unit, are clearly the most popular. Among women who pay for their
method, median cost is highest for surgical contraception, at about US$30. Available methods for
postpartum women include LAM, IUCDs, sterilization, progestogen-only pills, injectables, and
condoms, with injectables again being the most common (Gebreselassie, Rutstein, and Mishra
2008; DRH and MOPHS 2010).
In collaboration with development partners, the Ministry of Public Health and Sanitation (MOPHS)
and the Ministry of Medical Services (MOMS) developed a Costed Implementation Plan (CIP) for FP
following the guidelines in the National Reproductive Health Policy 2007 and the National RH
Strategy 2009-2015. Interventions and activities to promote CPR that will increase as per
FP20206 commitments are outlined in CIP. The key thematic areas identified in CIP are human
resources, integration, commodity security, youth, advocacy, and demand creation. Other notable
interventions include the Tupange project,7 funded by BMGF under its Urban Health Reproductive
Initiative (URHI), which aims to increase CPR by 20 percentage points in selected project areas in
Kakamega, Kisumu, Machakos, Mombasa, and Nairobi. Expanding the role of the private sector
will not only accelerate Kenya’s progress toward the FP2020 goals but also enable the Kenyan
government to redirect investment on other health priorities.

STUDY OBJECTIVES
The overall goal of the study was to generate evidence on the potential market dynamics that will inform
the introduction of a new contraceptive method in sub-Saharan Africa. The specific objectives of the study
were to:

1) Obtain reliable estimate of consumers’ demand for the PVR in Kenya by studying the effect of
price on demand;
2) Assess the “Willingness to Provide” by family planning providers and “Willingness to Procure” by
procurers;
3) Facilitate evidence-based pricing for the PVR in the three sectors of interest—public, private
nonprofit, and private commercial; and
4) Explore respondents’ WTP for future vaginal rings (including long-acting, reversible options for
nonbreastfeeding women) to assess potential demand and design access strategies.

6
7

FP2020: http://www.familyplanning2020.org/.
Tupange Project: http://www.tupange.or.ke/.
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Methods
STUDY DESIGN AND METHODOLOGY
A cross-sectional study was conducted in three countries in sub-Saharan Africa (Kenya, Nigeria, and
Senegal). The study used a multidimensional and multisectoral approach, which examined willingness to
pay for the PVR in the three countries. These approaches included:
Stakeholder-driven approach to WTP: We identified three actors in the PVR WTP assessment landscape—
potential consumers, providers, and procurers. We explored the three dimensions of WTP—WT Pay, WT
Provide, and WT Procure—by incorporating the voices of these three stakeholders in the data collection
tools.
Sector-driven approach to WTP: Using the guiding principles of improved access, efficient use of public
resources, and increased equity, we explored a potential total market model for the PVR by exploring the
views and expectations of different sectors that serve FP customers—the public, private nonprofit, and
private commercial sectors.
Table 3 summarizes the survey tools and methodology used in this WTP study including specific survey
instruments that were designed for target respondents.
TABLE 3 Study design, methodology, and scope
Stakeholder

Survey Instrument

Target Respondents

Consumers

a) WT Pay Survey
b) Price-Tracking Survey

a) Potential consumers (women aged 18–49 years old)
b) Pharmacists; facilities in charge at social marketing
outlets; and public FP clinics

Providers

WT Provide Survey

FP service providers and members of professional
associations, such as pharmacists, ob/gyns, midwives,
nurses, other providers

Procurers

WT Procure Survey

MOH, USAID Mission, UNFPA, MSI/Kenya, and large
pharma distributors

The WTP study was conducted in Nairobi County because the county has the highest concentration of
urban, educated women from more wealthy households. Since FP is provided free of charge in Kenya, it is
important to know if there is a segment of the population that will be able to pay for the ring—either
subsidized or full price—especially since there is a deliberate global effort to have all economies move to
a total market approach. In addition, Nairobi also has the highest concentration of health care facilities
and agencies involved in procuring FP commodities. Study populations were:
a) Numbering close to 400 women (397) aged 18–49 years seeking family planning services at
selected health facilities in Nairobi County. The total number of participants was distributed as
follows: public (278); private nonprofit (14) and private commercial (105). Questions on
consumer characteristics were included to gauge household expenses, family income, and
discretionary expenses, which will determine “ability to pay” for the PVR. Questionnaires were
designed using the standard format for the Contingent Valuation Methodology (CVM), which has
three sections: (1) socioeconomic background; (2) knowledge and need for postpartum FP; and
(3) WTP for the PVR.
7

b) Family planning service providers aged 18 years and above in selected health facilities. We
interviewed 10 providers from the initial pilot sites and 50 other providers drawn from health
facilities that were not part of the PVR pilot study. The providers were asked qualitative questions
to gauge their willingness to provide the PVR as part of the existing FP method mix in their health
facilities.
In addition, they were asked to estimate the maximum amount that should be charged (if any) for
providing the PVR. Respondents included randomly selected FP providers such as gynecologists,
nurses and midwives, clinical officers, and pharmacists.
c) In charge of selected health facilities. A total of 50 health facilities were assessed in the pricetracking survey. Out of this total, 17 were from the public sector, 6 were from the private
nonprofit sector, and 27 were from the private commercial sector.
d) Representatives of government, social marketing, and donor agencies involved in procuring FP
commodities. Out of 23 procurers who were interviewed, 3 were from the public sector; 8 were
from the private nonprofit sector, and 12 were from private commercial sector.
e) Procurers were asked to provide the price list of procured FP commodities and their assessment
of a reasonable price estimate for procuring the PVR, to assess their “willingness to procure” it.
After being provided with a detailed description of the PVR, procurers were asked their willingness
to buy the PVR for a modest starter price and then to state their maximum willingness to pay to
procure the PVR.
In conducting the survey, the following procedures were followed:
Since the PVR is a new product, respondents were shown a product sample and provided a full
description, including the ring’s use and benefits. Examples were given to draw connections with
comparable products, such as progestogen-only pills.
To reduce bias, user interest was ascertained by providing an option to rate interest in the PVR before
starting the survey. Uninterested respondents were not interviewed.
Different WTP price references for the PVR were used depending on the type of sector where clients who
were interviewed had gone to seek services. For instance, in the public sector, data was captured on the
maximum service fee that the potential user was willing to pay for the PVR.
In the private nonprofit sector, the WTP measure was the subsidized price for the PVR that the potential
user was willing to pay. In the private commercial sector, the WTP measure referred to the maximum
selling price the consumer was willing to pay.
We used the current price of a three-month supply of Progestogen-only pills before determining the
hypothetical price ranges we tested. Questions for respondents started with a modest price assumption
for the PVR of KES90 (US$0.90) in the public sector; KES120 (US$1.20) in the private nonprofit sector,
and KES150 (US$1.50) in the private commercial sector.
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We ended the interview with two open-ended questions: (1) We asked the maximum price the respondent
was willing to pay for the PVR independent of the previously mentioned prices; (2) We sought to know the
possible action the respondent would take if the price were found to be too high. See Figure 1 for the
sequence of questions asked, which were adapted from Foreit and Foreit (2001).

FIGURE 1 CONSUMER SURVEY: BIDDING GAME MODEL
Q1

Q2

Q4

Q3

Q5

Higher increase
(fixed)

Starter
price
(fixed)
Price of 3month
supply of
POPs

Price after 20%
increase

Moderate
increase
(fixed)
Price after
10% increase

Maximum WTP
(independently)
Lower increase
(fixed)

What would
you do if
the price
were too
high?

Price after 5%
increase

SOURCE: Foreit and Foreit (2001). POPs = Progestogen-only pills.

DATA COLLECTION
The Ethics and Research Committee (ERC) of Kenyatta National Hospital, University of Nairobi granted
ethical clearance for the study. The National Commission for Science, Technology, and Innovation
(NACOSTI) granted the research permit for the study.
The data collected were manually entered into EPI DATA. A direct estimation model for calculating the
demand curve as described in the WTP study manual was used (Foreit and Foreit 2001). All responses
with a maximum WTP price were checked for internal consistency. (The maximum price stated had to
be equal to or higher than the highest price accepted. Demand curves were derived from frequency
distributions of the maximum WTP price.) The WTP technique described here includes the assumption
that only the price varies and all other factors remain constant.
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Results
The WTP study was structured into four components: namely a price-tracking survey, interviews with
potential consumers, and a survey among providers and procurers. Table 4 shows the sample sizes
achieved by study components and sectors surveyed.

TABLE 4

Sample sizes achieved by study component and sector

Type of Method

Public Sector

Private Nonprofit
Sector

Private Commercial
Sector

N

Percentage

n

%

n

%

n

%

Price-Tracking

17

34

6

12

27

54

50

100

Consumers

278

70

14

4

105

26

397

100

Providers

17

27

6

9

41

64

64

100

Procurers

3

13

8

35

12

52

23

100

PRICE-TRACKING SURVEY
As shown in Table 4, 17 public sector facilities, 6 private nonprofit facilities, and 27 private commercial
facilities participated in the survey. Health providers in charge of facilities (doctors, nurses, clinical
officers), or pharmacists or other pharmacy staff in the case of chemists, were asked to name
contraceptives available in their respective facilities and the corresponding price(s) for each category of
contraceptives on the day of the interview.
Contraceptives that were in stock most of the time were injectables (Depo-Provera or DMPA), implants
(Jadelle), pills (Progestogen-only pills or Microlut, combined oral contraceptives or Femiplan), and male
condoms. Others were emergency contraceptive pills and copper intrauterine devices (IUDs).
Respondents in public health facilities pointed out that breastfeeding women in the postpartum period
were facing a challenge in accessing a suitable FP method due to frequent and prolonged stock-out of
Microlut.
The majority of respondents in public sector facilities indicated that they dispensed or issued
contraceptives to their clients free of charge as per government policy.8 However, respondents in the
private nonprofit and private commercial sectors said that they levied a fee for various types of
contraceptives even if the source of the contraceptives was the Kenya Medical Supplies Agency (KEMSA),
which is a government institution under the Ministry of Health.
As shown in Table 5, the median price of injectables (or DMPA) was KES100 (US$1) across the private
nonprofit and private commercial sectors. The median price for pills was much lower in the private
nonprofit sector at KES20 (US$0.2). The cost of implants was much higher in the private commercial
sector at KES1,000 (US$10). Most of the respondents acknowledged that the price of contraceptives
shown in Table 5 included a markup to cover labor costs and other recurrent costs at the facility or within

8

Ministry of Health, Republic of Kenya (2000): “Family Planning and Reproductive Health Commodities in Kenya Background Information for
Policymakers.”

10

the program or management chain that was responsible for running the facility or chemist(s). Most of the
respondents were not aware of the exact figure for the markup. They indicated that the business owners
knew the percentage of markup or taxation. This finding is similar in other countries (Nigeria and Senegal)
as well.
TABLE 5

Median prices of commonly available contraceptives by sector in Kenya
Brand

Median Price (KES)

Median Price (USD)

Private Nonprofit Sector
Injectables

Depo-Provera

100

1

Implants

Jadelle

400

4

Pills

Microlut

20

0.2

Injectables

Depo-Provera

100

1

Implants

Jadelle

1,000

10

Pills

Microlut

100

1

Private Commercial Sector

Frequency of Fee Structure Changes
Regarding the frequency of changes to the fee structure for contraceptive methods, a significant
proportion of respondents in the private nonprofit and private commercial sectors said that their fee
structure does not change very often and remains relatively stable for extended periods of time. A few of
them said that the fees did change on a weekly basis. Others said that the fees could even change on a
daily basis. Four of the respondents said that they changed the fees on a quarterly basis. Three
respondents said that they changed the fees semi-annually. The rest of the respondents said that the
change in fees levied was dependent on the manufacturers’ conditions, including the going price as well
as the supply and demand for pharmaceuticals in general and for contraceptives in particular.

Frequency of Contraceptive Stock Delivery
The majority of respondents said that they received contraceptive stocks in less than a month. Some
mentioned quarterly supply, especially those who receive stocks directly from government stores (i.e., the
Kenya Medical Supplies Agency). A smaller proportion of respondents mentioned that they received their
stocks semi-annually or annually.

General Comments and Observations of Respondents
At the end of the interview, the interviewer provided an opportunity for respondents to ask questions or
offer observations regarding the interview. The majority of respondents asked whether staff in the private
sector would be considered for training on the PVR. Others wanted to know whether the PVR would
replace Microlut, which has not been in stock for quite some time. Respondents raised the issue of
hygiene and potential infection if proper hygiene measures are not taken with the PVR. Some
respondents asked whether men would be allowed to purchase the PVR for their partners. Others pointed
out that FP commodities are free of charge in government health facilities and asked whether the PVR will
also be free of charge in those facilities. Some observed that the PVR would expand method mix,
especially for women in the postpartum period.
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CONSUMER SURVEY
Demographic Characteristics of Study Participants by Sector
TABLE 6 Demographic characteristics of study participants by sector
Public Sector
(n=278)

Private Nonprofit Sector
(n=14)

Private Commercial Sector
(n=105)

%

%

%

15–19

4

0

1

20–24

41

43

26

25–29

35

21

43

30–34

14

7

18

>35

7

29

12

None, never attended

0

0

2

Primary

37

43

14

Secondary

46

36

27

College/graduate

17

43

57

Married

90

64

83

Not currently married

10

36

17

Housework/not working

45

29

27

Business

20

29

22

Government

1

0

11

Manual/temporary work

10

0

6

Student

2

21

8

Other

22

21

27

Business

28

0

33

Government

10

22

27

Manual/temporary work

30

34

11

Other

32

44

29

Variable

Age

Highest Level of Education

Marital Status

Employment Status

Spouse Employment Status

As shown in Table 6, the majority of the clients who were interviewed in the public sector (41%) and
private nonprofit sector (43%) were between 20 and 24 years of age. The majority of those interviewed
from the private sector were between 25 and 29 years of age. A majority (46%) of those interviewed in
the public sector had secondary education, 43% of those interviewed in the private nonprofit sector had
both primary and college/graduate education, while 57% of those interviewed from the private
commercial sector had college/graduate education. Most of the clients interviewed in the public (90%)
and private commercial (83%) sectors were married, compared to 64% in the private nonprofit sector.
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Overall, the spouses of the clients who were interviewed were twice as likely to be engaged in business or
in manual/temporary work compared to the women themselves. None of the respondents and partners
who were interviewed at the private nonprofit health facilities cited the government as the institution or
place where they are employed.
These findings contrast with those obtained from respondents who sought services from private for-profit
health facilities, where 27% of spouses cited the government as a place where they are employed. In
summary, respondents who were interviewed in the private commercial sector presented a higher
socioeconomic profile.

Socioeconomic Characteristics of Study Participants by Sector
TABLE 7a Sociodemographic characteristics of study participants by sector
Variable

Public Sector
(n=278)

Private Nonprofit
Sector (n=14)

Private Commercial
Sector (n=105)

%

%

%

1

48

27

28

2

34

18

50

3

14

55

14

4+

5

0

8

Not using and does not intend to use in the future

4

7

6

Yes, currently using

82

71

79

Not currently using, but intends to use in the future

14

14

15

<50

29

0

1

50–199

50

33

58

200–499

4

33

10

500–999

7

17

16

>1,000

11

17

15

Television

80

86

97

Refrigerator

13

14

57

Vehicle

7

14

26

Mobile

99

93

100

Radio

82

86

87

Number of Children

Family Planning Use

Monthly FP Expense (KES)

Household Items

The socioeconomic characteristics of study participants addressed in this section are: a) number of
children; b) family planning use; c) monthly FP expenditure; and d) household items (Table 7a). Nearly
half of the women (48%) who were interviewed in the public sector had given birth to one child.
Nearly 55% of those interviewed in the private nonprofit sector had at least 3 children, while 50% of those
interviewed from the private commercial sector had 2 children. The majority of the women were current
users of FP services. As expected, most of those who paid for FP services were interviewed at the private
commercial sector facilities with the majority spending between KES 50–199 (US$0.5–$2) per month.
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A much higher proportion of women (58%) who were interviewed at the private sector commercial
facilities spent between KES50–199 (US$0.5–$2) per month on FP services compared to those who
sought services in the public and nonprofit sectors.
The majority of clients interviewed at the private commercial sector facilities possessed most of the
household items, such as televisions, compared to those who sought services from the public and
nonprofit health facilities. Those clients who sought services from the public facilities had the least
amount of household items, followed by the private nonprofit health facilities. No differences were noted
in mobile phone ownership across the three sectors, indicating that the level of discretionary spending on
mobile phone use may be similar. This also suggests that mobile services may be useful in PVR client
counseling or follow-up.

Visits to Hair Salon, Monthly Expenditure, and Income Level
TABLE 7b Sociodemographic characteristics of study participants by sector
Public Sector
(n=278)

Private Nonprofit
Sector (n=14)

Private Commercial
Sector (n=105)

%

%

%

Weekly

5

0

11

Monthly

65

79

64

Other

19

21

16

Do not know

11

0.0

9

<50,000

97

84

69

50,000–100,000

3

8

19

>100,000

0

8

12

Low (<10,000)

13

27

3

Medium (10,000–100,000)

84

73

74

High (>100,000)

3

0

23

Variable

Salon Visits

Monthly Expenditure (KES)

Income Level (KES)

The average monthly expenditure for the majority of clients (97%) who sought services from the public
sector was less than KES50,000 (US$500). Approximately 12% of the clients who sought services from
the private commercial sectors spent over KES100,000 (US$1,000) per month. None of the clients spent
more than KES100,000 (US$1,000) to seek services in the public sector. Approximately 84% of the
clients who sought services from the public sector had a monthly income that ranged from KES10,000–
100,000, whereas 12% of the clients who sought services from the private or commercial sector facilities
spent over KES100,000 (US $1,000). None of the clients interviewed while seeking services from the
private nonprofit sector had a monthly total income of over KES100,000 (US $1,000). (Table 7b.) These
data confirm that respondents from the private sector are economically more advantaged than those who
were interviewed at public sector facilities. Furthermore, a comparison of the two sectors suggests that
the public sector may be serving some who could potentially pay for services and should ideally be
seeking services in the private sector.
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Consumer Interest in Purchasing the PVR
As shown in Table 8, potential consumers indicated that they would be interested in purchasing the PVR if
it becomes available in the future.
TABLE 8

Consumer interest in purchasing the PVR by sector
Public Sector
(n=278)

Variable

Private Nonprofit
Sector (n=14)

Private Commercial
Sector (n=105)

Total

n

%

n

%

n

%

n

%

Yes, I would be interested in
purchasing the PVR

192

69

9

64

68

65

269

68

No, I would not be interested
in purchasing the PVR

86

31

5

36

37

35

128

32

Total

278

100

14

100

105

100

397

100

As shown in Table 8, out of the 397 respondents interviewed, 269 (68%) were willing to purchase the PVR
if it were made available in future. The responses were similar across all sectors (public, private nonprofit,
and private commercial).

Reference Prices for Willingness to Pay (WTP) by Sector
The reference WTP prices for the PVR by sector are shown in Table 9.
TABLE 9

Reference WTP Prices for the PVR by Sector
Public Sector (KES)

Private Nonprofit Sector
(KES)

Private Commercial
Sector (KES)

Starter price

90 (US$0.90)

120 (US$1.20)

150 (US$1.50)

Price after 10% increase

100 (US$1.00)

130 (US$1.30)

165 (US$1.65)

Price after 20% increase

110 (US$1.10)

145 (US$1.45)

180 (US$1.80)

Price after 5% decrease

85 (US$0.85)

115 (US$1.15)

145 (US$1.45)

Provider Profile

WTP for the PVR
Respondents were asked a series of questions regarding their willingness to pay for the PVR at the starter
price, at a 10% increment, and at a 20% increment. The responses to the respective questions are
outlined in Table 10.
TABLE 10

WTP for the PVR by starter price, level of increment, and sector
Public Sector
(n=278)

Private Nonprofit
Sector (n=14)

Private Commercial
Sector (n=105)

Total

n

%

n

%

n

%

n

%

Respondents interested
in the PVR

192

69

9

64

69

66

270

68

Starter price

164

85

9

100

68

98

241

89

10% increment

147

77

9

100

57

83

213

79

20% increment

86

45

5

56

52

75

143

53
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As seen in Table 10, 68% were interested in the PVR with little difference across the sectors. The demand
for the PVR at the starter price equaled 89%, with variations across the sectors. Most of those interviewed
in the public sector (85%) were willing to pay at a starter price of KES90 (US$0.90) and all those
interviewed in the private nonprofit sector were willing to pay at a starter price of KES120 (US$1.20).
Approximately 98% of those who sought services from the private commercial sector were willing to pay
KES150 (US$1.50) as a starter price.
Furthermore, it is interesting to note that with price increases, although there is an expected decline in
the proportion willing to pay the new price, there is also a clear pattern. At a 20% increment, respondents
in the public sector are most sensitive to the price change, followed by the private nonprofit and private
commercial sectors. This pattern confirms our belief that paying users of the PVR are likely to be in the
private sector.

WTP More for Women in Low-Resource Settings
A significant proportion of respondents were willing to help women in low-resource settings access
contraceptive services. For instance, 77% of clients (Table 11) indicated that they were willing to pay the
maximum amount quoted, plus a 5% increase over the price if it can be used to fund contraceptive supply
for women in low-resource settings.
TABLE 11

Respondents’ WTP more to fund contraceptive supply for women in low-resource settings

Response

Public Sector (n=190)

Private Nonprofit
Sector (n=9)

Private Commercial
Sector (n=68)

Total

n

%

n

%

n

%

n

%

Yes, willing to pay

140

74

6

67

59

87

205

77

No, not willing to
pay

42

22

3

33

8

12

53

20

8

4

0

0

1

1

9

3

190

100

9

100

68

100

267

100

Do not know
Total

WTP Maximum Price for the PVR
As shown in Table 12, 94% of clients were willing to pay less than KES500 (US$5) for the PVR. Of those
respondents who were willing to pay less than KES500 (US$5), 98% sought services from the public
sector and 100% from the private nonprofit sector. At least 6% of clients were willing to pay more than
KES500 (US$5) for the PVR.
TABLE 12
Maximum
Price (KES)
<500

Respondents WTP maximum price for the PVR
Public Sector (n=191)

Private Nonprofit
Sector (n=9)

Private Commercial
Sector (n=69)

Total

n

%

n

%

n

%

n

%

188

98

9

100

57

83

254

94

500–1,000

2

1

0

0

9

13

11

4

1,000–1,500

0

0

0

0

3

4

3

1

>1,500

1

1

0

0

0

0

1

1

191

100

9

100

69

100

269

100

Total
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Reasons for Agreeing to Pay
Those respondents who agreed to pay more, including a 5% increase, cited a number of reasons for doing
so. Some said that the price was affordable and desired an FP method for use during the postpartum
period. Others reported that an unintended pregnancy could lead to medical complications and higher
expenses in the management of such complications. Hence paying for an FP method instead of
anticipating complications related to pregnancy was the rationale. The respondents who were not willing
to pay more, including a 5% increase over the price, believed that the price was too high and noted the
fact that there were less expensive alternatives on the market.

Suppose the Selling Price of the PVR Is Too High?
A majority of the respondents said that they would look for affordable alternatives (52%) and go to places
where the PVR is given free of charge (27%) if the selling price of the PVR turns out to be too high for
them. Most of the respondents who cited affordability issues sought services from the private nonprofit
sector followed by those who sought services from the public sector.

Consumer Demand Curve for PVR by Sector
In this section, two sets of consumer demand curves for the PVR are shown, namely the public and
private commercial sectors. The demand curve for the private sector combines the clients who were seen
in the private nonprofit and private commercial sectors. Combining views of clients from the private
commercial sector and those of clients who were seen at the private nonprofit facilities was done due to
the small sample size for the latter group.

Public Sector Consumer Demand Curve
As shown in Figure 2, a majority of respondents in the public sector were willing to pay up to KES500
(US$5) for the PVR. The proportion of respondents who were willing to pay between KES500 (US$5) and
KES2,100 (US$21) for the PVR drops dramatically at prices over KES500 and is almost negligible among
public sector clients.

FIGURE 2 CONSUMER DEMAND CURVE FOR THE PVR—PUBLIC SECTOR
120

Demand (%WTP)

100

100%

80
60

69%

40
20

16%
6%

5%

0.5%

0

0

n=191
Maximum Price (KES)
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The steep drop in the demand for the PVR if the price exceeds KES500 (US$5) could be attributed to low
income levels in the target community or among potential users. For instance, when public sector
respondents were asked what form of transportation they used to travel to work, school or market,
roughly 50% reported using public transportation, 41% said they walked, and 1% reported owning a
vehicle. As noted earlier, the mean hair salon expense per visit for public sector respondents was
KES660 (US$6.60). These respondents also made less visits to the salon compared to clients who sought
FP services in the private sector.

Private Sector Consumer Demand Curve
As seen in Figure 3, the consumer demand curve for private sector respondents was less steep. For
instance, a significant proportion of the clients were willing to pay for the PVR even if the price exceeded
KES500 (US$5).
FIGURE 3 CONSUMER DEMAND CURVE FOR THE PVR—PRIVATE NONPROFIT AND
COMMERCIAL SECTORS
120
Demand (%WTP)

100

97%

80
60

65%

40
20

30%

24%

15%

14%

12%

0

4%

0

Maximum Price (KES)
n=78

The shape of the consumer demand curve for the private sector is consistent with the observation made
earlier (see Table 7b) regarding visits to hair salons. The mean salon expense per visit for private sector
respondent was KES1,160 (US $11.6) and private sector respondents made more weekly visits to salons
compared to public sector respondents.
In addition, about 70% of private sector clients were willing to pay for contraceptives, compared to only
30% of the clients who sought services from the public sector health facilities.

Reasons for WTP for the PVR
Respondents cited many reasons for their willingness to pay for the PVR (Figure 4). For instance, 45% of
the private sector respondents and 35% of the public sector respondents mentioned an “affordable
price.” Other responses included:


Provider recommendation (public sector 11%, private sector 9%);



Wanting or liking the method (public sector 19%, private sector 18%);



Do not want unintended pregnancy (public sector 16%, private sector 23%); and



I want to help women get access to this FP method (public sector 51%, private sector 46%).
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It is worth pointing out that except for in the case of affordability, where the proportion of respondents in
the private sector was clearly greater than that in the public sector, the rest of the responses were more
or less similar across sectors. The least cited reason for respondents’ willingness to pay for the PVR was a
“provider recommendation,” which was only cited by 11% in the public sector and 9% in the private
sector.
FIGURE 4 REASONS FOR WTP FOR THE PVR BY SECTOR
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WTP for a One-Year Contraceptive Vaginal Ring (CVR) for Nonbreastfeeding Women
Respondents who participated in the WTP for the PVR were also asked if they would be interested in
using a new type of method with different features, namely a long-acting reversible contraceptive vaginal
ring (CVR) for nonbreastfeeding women. Since the nonbreastfeeding ring is a new product, respondents
were provided with a full product description including its use and benefits, and the fact that it can be
used for up to one year and is meant for nonbreastfeeding women. Examples were given to draw
connections with comparable products such as implants.
To reduce bias, user interest was ascertained by providing an option to rate interest in the one-year CVR
before proceeding with the interview. Thus, we specifically asked if they would be interested in using a
new type of contraceptive method that is long-acting and reversible for nonbreastfeeding women.
Uninterested respondents were not interviewed.
Different WTP price references for the long-acting ring for nonbreastfeeding women were used depending
on the type of sector where clients who were interviewed had gone to seek services. The current price of
providing long-acting and reversible FP methods such as implants in the public, private nonprofit, and
private commercial sectors was used in estimating the potential market price for the long-acting ring for
nonbreastfeeding women. We ended the interview by asking the maximum price that the participant was
willing to pay for the one-year CVR independent of the previously mentioned prices.

19

The responses from clients with regard to their interest in using the one-year CVR are outlined in
Table 13.
TABLE 13

Respondents’ interest in the one-year CVR
Public Sector
(n=268)

Response

Yes, interested

Private Nonprofit
Sector (n=13)

Private Commercial
Sector (n=98)

Total

n

%

n

%

n

%

n

%

177

66

11

85

61

62

249

66

No, not interested

91

34

2

15

37

38

130

34

Total

268

100

13

100

98

100

379

100

Most of the respondents (66%) in the public sector reported being interested in the one-year CVR.
Respondents who sought services in the private nonprofit sector (85%) were most likely to agree to use
the one-year CVR compared to 66% in the public sector and 62% in the private commercial sector.

Reference Prices for WTP for the One-Year CVR
The reference WTP prices for the one-year CVR are shown in Table 14.
TABLE 14

Reference WTP Prices for the One-Year CVR
Public Sector (KES)

Private Nonprofit
Sector (KES)

Private Commercial
Sector (KES)

Starter price

640 (US$6.40)

730 (US$7.30)

915 (US$9.15)

Price after 10% increase

705 (US$7.05)

800 (US$8.00)

1,005 (US$10.05)

Price after 20% increase

770 (US$7.70)

880 (US$8.80)

1,100 (US$11.00)

Price after 5% decrease

610 (US$6.10)

695 (US$6.95)

870 (US$8.70)

WTP for the One-Year CVR
Respondents who had expressed interest in the one-year CVR were asked a series of questions to gauge
their interest and willingness to pay the starter price, at a 10% increment, and at a 20% increment. The
responses to the respective questions are outlined in Table 15.
TABLE 15

WTP for the one-year CVR by starter price, level of increment, and sector
Public Sector
(n=177)

Private Nonprofit
Sector (n=11)

Private Commercial
Sector (n=61)

Total

n

%

n

%

n

%

n

%

Respondents interested
in the one-year CVR

177

66

11

85

61

62

249

66

Starter price

89

50

7

64

43

71

139

56

10% increment

56

63

3

43

33

75

92

66

20% increment

42

75

3

100

30

91

75

82
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A significant proportion of respondents were willing to pay for the one-year CVR even at higher prices. A
majority of clients interviewed in the private commercial sector were willing to pay for the one-year CVR
compared with those interviewed in the public and private nonprofit sectors. Public (50%), private
nonprofit (64%), and private commercial sectors (71%) expressed their willingness to pay for the one-year
CVR at the starter price.

WTP Maximum Price for the One-Year CVR
The responses on the maximum amount of money respondents would be willing to pay for the one-year
CVR are shown in Table 16.
TABLE 16

Respondents WTP maximum price for one-year CVR

Max Price (KES)

Public Sector (n=175)

Private Nonprofit
Sector (n=11)

Private Commercial
Sector (n=60)

Total

n

%

n

%

n

%

n

%

<500

97

55

6

55

15

25

118

48

500–1,000

74

42

4

36

18

13

96

39

1,000–1,500

1

1

1

9

11

18

13

5

>1,500

3

2

0

0

16

27

19

8

175

100

11

100

60

100

246

100

Total

About half (48%) of the respondents were willing to pay less than KES500 (US$5). The clients interviewed
in public sector were the majority in this category (55%), compared to private commercial respondents
where 25% agreed to pay less than KES500 (US $5).

WTP Maximum Price Plus a 5% Increase
A significant proportion of respondents were willing to help women in low-resource settings access the
one-year CVR. For instance, 66% of women were willing to pay the maximum price plus a 5% increase
over the maximum price if it can help widen FP access to women in low-resource settings (Table 17).
About 77% of the respondents who were willing to pay the maximum price plus a 5% increment were in
the private commercial sector.
TABLE 17

Respondents WTP maximum price plus a 5% increase

Response

Public Sector
(n=190)

Private Nonprofit
Sector (n=9)

Private Commercial
Sector (n=68)

Total

n

%

n

%

n

%

n

%

Yes, willing to pay

106

63

6

55

44

77

156

66

No, not willing to pay

55

33

5

45

11

19

71

30

Do not know
Total

7

4

0

0

2

4

9

4

168

100

11

100

57

100

236

100
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Consumer Demand Curve for One-Year CVR
In this section, two sets of consumer demand curves for the one-year CVR are shown, namely the public
and private commercial sectors. The demand curve for the private sector combines the clients who were
seen at the private nonprofit and private commercial facilities due to the small sample size for the latter
group.

Public Sector Consumer Demand Curve
As shown in Figure 5, approximately 50% of the respondents in the public sector were willing to pay
KES700 (US$7) for the one-year CVR. The WTP drops off substantially and tapers to less than 10% at
prices over KES1,200, although there were a few potential clients who were willing to pay up to
KES3,000 (US$30).

FIGURE 5 CONSUMER DEMAND FOR ONE-YEAR CVR—PUBLIC SECTOR
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Private Sector Consumer Demand Curve
Compared to the demand curve in the public sector, the slope of the private sector demand curve is more
gradual. As shown in Figure 6, approximately 50% of the respondents in the private sector were willing to
pay KES1,250 (US$12.5) for the one-year ring, with a significant proportion (23%) willing to pay
KES2,000. A few of the potential clients suggested they would pay up to KES4,000 (US$40).
As seen in Figures 5 and 6, private sector clients were willing to pay a higher price for the one-year ring
compared to public sector clients.
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FIGURE 6 CONSUMER DEMAND FOR ONE-YEAR CVR—PRIVATE NONPROFIT AND
COMMERCIAL SECTORS
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PROVIDER SURVEY
Sixty-four (64) providers were interviewed (17 from the public sector, 6 from the nonprofit private sector,
and 41 from the private commercial sector). Sixty-two (62) of the providers had a college/university level
of education, while two (2) had a secondary level of education. It should also be noted that the most
popular methods on the market among clients are injectables, implants, and pills.

Inclusion of the PVR into Available Contraception Options
Research assistants were required to show a sample of the PVR to respondents as well as give them a
brief description of the product including what it is and how it works. After providing a description of the
product, respondents were then asked if they would support the inclusion of the PVR in the available FP
options. Out of the 64 providers, nearly all of them (98%) said they would support the inclusion of the
PVR. Only one respondent (2%) answered otherwise.
In a related question, providers were requested to mention the most important reason for liking the PVR.
Most of them cited “easy to use” (60%).

Willingness to Provide the PVR to Clients If It Becomes Available
Providers were asked whether they would be willing to provide the product to their clients if it becomes
available. In response to this question, all 64 providers (100%) answered in the affirmative. Providers
also gave an opinion on whether their clients would like the PVR. About 75% of providers suggested that
their clients would like the product. Close to 10% indicated that their clients would not like the product,
and the remaining 15% indicated that they did not know.
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Providers’ Opinion Regarding Price for the PVR
Providers were asked to give an opinion on what they thought was an appropriate price for the PVR. Table
18 shows the smallest and the highest amount of money suggested by providers in each sector with the
corresponding interquartile range, mean, and median amount.
TABLE 18 Providers’ opinion on appropriate price for the PVR by sector
Smallest Amount Highest Amount
(KES)
(KES)

Interquartile Range
(KES)

Mean (KES)

Median (KES)

100 (US$1)

50 (US$0.5)

78 (US$0.78)

100 (US$1)

50 (US$0.5)

3,000 (US$30)

150 (US$1.5)

583 (US$5.83)

100 (US$1)

38

0 (US$0)

8,000 (US$80)

400 (US$4)

697 (US$6.97)

200 (US$2)

60

0 (US$0)

8,000 (US$80)

200 (US$2)

521 (US$5.21)

100 (US$1)

Sector

n

Public

16

50 (US$0.5)

Donors

6

Private nonprofit
Private commercial

The median price suggested for the PVR was KES100 (US$1) in both the public and private nonprofit
sectors. Compared to the public sector, mean and interquartile range was much higher in the private
nonprofit sector. The median price for the PVR in the private commercial sector was KES200 (US$2) with
a much larger interquartile range and mean compared to the public and private nonprofit sectors. Some
of the providers suggested that an appropriate price for the PVR would be KES8,000 (US$80).

Assessing Health Providers’ Interest in the One-Year CVR
Providers were asked whether they would be interested in the one-year CVR. Out of the 64 providers
interviewed, 59 of them (93%) responded in the affirmative. Only four (6%) were not interested. In a
related question, providers were requested to mention the most important reason for liking the one-year
CVR. Most of them cited the following reasons: long-acting (73%), used for nonbreastfeeding women (2%),
and other (25%). (Data not shown.)

Willingness to Provide the One-Year CVR If It Becomes Available
All 59 providers (100%) said that they were willing to provide the one-year CVR to their clients if it
becomes available. Out of the 59 providers, 86% said that their clients would like the one-year CVR, 2%
said that their clients would not like it, and 12% said that they did not know. (Data not shown.)

Providers’ Opinion Regarding Price for the One-Year CVR
Providers were asked to give an opinion on what they thought was an appropriate price for the long-acting
ring for nonbreastfeeding women. Table 19 shows the smallest and the highest amount of money suggested
by providers in each sector with the corresponding interquartile range, mean, and median amount.
TABLE 19 Providers’ opinion on appropriate price for the one-year CVR by sector
n

Smallest Amount
(KES)

Highest Amount
(KES)

Interquartile range
(KES)

Mean (KES)

Median
(KES)

Public

16

20 (US$0.2)

500 (US$5)

150 (US$1.50)

176 (US$1.76)

100 (US$1)

Donors

5

30 (US$0.3)

8500 (US$85)

1050 (US$10.50)

2076 (US$20.76)

400 (US$4)

Private nonprofit

36

100 (US$1)

10,000 (US$100)

750 (US$7.5)

1,088 (US$10.88)

500 (US$5)

Private commercial

57

20 (US$0.2)

10,000 (US$100)

300 (US$3)

918 (US$9.18)

300 (US$3)

Sector
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The median price for the one-year CVR was KES100 (US$1) in the public sector. The median price in the
private nonprofit sector was KES500 (US$5) with a much larger interquartile range of KES750 (US$7.5)
and mean of KES1,088 (US$10.88) compared to the public sector. The median price for the one-year
CVR in the private commercial sector was KES300 (US$3) with an interquartile range of KES300 (US$3)
and mean of KES918 (US$9.18). Some of the providers in the private commercial sector suggested that
an appropriate price for the one-year CVR would be KES10,000 (US $100).
A comparison of the lowest and highest prices that providers were willing to pay for the PVR and one- year
CVR is made in Figure 7.
FIGURE 7 WTP (AS QUOTED BY PROVIDERS) FOR THE PVR AND ONE-YEAR CVR
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As can be seen, providers suggested much higher prices for the longer-lasting ring compared to the PVR.

PROCURER SURVEY
Twenty-three (23) procurers were interviewed—three from government, two represented donors, six from
the private nonprofit sector, nine from the private commercial sector, and three others (Table 20).
The private commercial sector constituted the largest group of procurers (39%).
TABLE 20 Procurers consulted during the PVR WTP study
Type

Frequency (n=23)

Percentage

Government

3

13

Donor

2

9

Private nonprofit

6

26

Private commercial

9

39

Other

3

13

Total

23

100
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Frequently Procured Contraceptive Methods
The most frequently procured contraceptives mentioned by respondents were combined oral
contraceptives (pills), injectables (DMPA), emergency contraceptive pills (Postinor-2), implants (Jadelle
and Implanon), and IUDs. Other respondents said that they do obtain contraceptives from the Kenya
Medical Supplies Agency (KEMSA) and then distribute or dispense to their clients.

Process of Procuring Contraceptives
Procurers were asked to describe the process of procuring contraceptives in their respective
organizations. The various approaches followed in procuring contraceptives are described in Box 1.
BOX 1 PROCESS OF PROCURING CONTRACEPTIVES













Done by national government in conjunction with KEMSA
We usually call the suppliers and then they deliver
We always do open tendering
Procurement office at the head office does it for us
We do quantification and forecasting based on consumption data
We fill in the order form and then send it to the supplier
We procure from importers
We approach manufacturers directly
We work closely with UNFPA, USAID, and the government to arrange for procurement
Tenders are issued out, then whoever wins the tender supplies the contraceptives
Once our products are out of stock, we call the supplier and make the order
Most of our procuring process takes place through global partnerships

Setting of Procurement Prices for Contraceptives
Procurers were given an opportunity to describe how procurement prices for contraceptives are set in
their respective organizations. The process or procedures followed in setting procurement prices for
contraceptives are outlined in Box 2.
BOX 2 PROCESS OF SETTING PROCUREMENT PRICES FOR CONTRACEPTIVES











The government usually initiates the process of setting procurement prices
The source or type of distributor determines the price of the drugs/FP at the pharmacy
Procurement prices vary a lot and are set by the supplier or importer
Determining the price is done centrally using international mechanisms within the company, which sets the
best access price
We negotiate for the cheapest prices directly from the manufacturers
Most of the time contraceptives are procured from outside Kenya and so procurement prices are set
internationally depending on the strength of the dollar or some other currency
We usually go for competitive prices. For example, the price of implants has come down because of the global
commitment to get more women access to effective FP methods.
Our company has already prescribed fixed prices for us. They recommend the prices we give.
There are different prices for suppliers and retailers. Supplier prices are done at the national level.
Other organizations negotiate with manufacturers so that the contraceptives can be purchased at the lowest
possible price depending on the strength of the dollar and yen.
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Frequency of Changes in Procurement Costs
Procurers were asked to describe the frequency of changes in procurement costs for contraceptives.
Different groups of procurers made the statements outlined in Box 3.

BOX 3 FREQUENCY OF CHANGES IN PROCUREMENT COSTS












Procurement costs vary monthly and depend on agents, distributors, or suppliers. When the supplier
increases the price, the chemists also increase the retail price. If they drop the price, the retail price also
drops.
Depends on demand. Sometimes the prices change twice a year.
Procurement costs rarely change. Sometimes they change annually. Prices could either increase or decrease
depending on demand and supply forces.
Usually increase due to additional annual taxation
We get most of the FP supplies from the Ministry of Health so we do not experience price changes
Changes in procurement costs depend on the raw materials, the cost to the government, and market prices
Price changes are dependent on what the manufacturer gives distributors or procurers
Price changes are not very common since we buy directly from a company (we try to keep it fixed)
Procurement costs hardly change. Maybe after every 5 years.
Procurement costs depend on the strength of the dollar and yen because most of the FP products are
manufactured overseas and so it would be difficult to answer this question directly

Family Planning Commodity Prices, Taxation, and Markup
Procurers were asked to confirm or acknowledge if pricing included taxes and markups. Their responses
are outlined in Table 21. About half of the respondents did not know whether the price charged included
a markup. A much bigger proportion (61%) of respondents said that the commodity prices did not include
taxes.
TABLE 21 Procurers’ views on commodity pricing, taxes, markup, and levels involved
Type

n

Percentage

Estimated Proportion of Taxation (for Yes Response)

Yes (pricing including
taxation)

9

39

16% (Value Added Tax); others said that taxes are included
in the pricing but did not know the rate or percentage.

No

14

61

N/A

Yes (pricing including
markup)

12

52

Ranges from 1.33% to 30%

No

11

48

N/A

Response (Taxation)

Response (Markup)

Quality Control Process for Procurement of New Contraceptives
Procurers were asked to describe the quality-control process that their respective organizations must
follow when procuring new contraceptives. Some of the examples that were offered by data collectors
(during the discussion) to clarify the question included WHO PQ, EML, and SRA. The responses to this
question are outlined in Table 22.
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TABLE 22 Quality-control process followed to procure new contraceptives
Type

n

Percentage

Follow quality-control standards of WHO/MOH/KEMSA

11

48

Organization has an internal quality-control department that assesses quality issues

3

13

Purchase only products that are already registered in Kenya

5

22

Organization manufactures commodities and has an internal mechanism for quality
assurance and appropriate infrastructure to maintain recommended conditions.

3

13

Buy commodities only from reliable sources

1

4

Total

23

100

The majority of respondents cited the quality-control process mandated by WHO and KEMSA as being the
reference point to be followed in procuring new contraceptives.

Assessing Procurers’ Interest in Purchasing the PVR
Procurers were asked whether they would be willing to purchase the PVR if it becomes available. In
response to this question, 19 out of the 23 procurers (83%) answered in the affirmative (Table 23). The
four procurers who showed no interest in purchasing the PVR are not involved in FP commodities. The
four procurers were all from the private commercial sector.
TABLE 23 Assessing procurers’ interest in purchasing the PVR
Type

Response

Total

Interested

Not Interested

Government

3

0

3

Donor

2

0

2

Private nonprofit

6

0

6

Private commercial

5

4

9

Others

3

0

3

Total

19

4

23

Procurers’ WTP Maximum Price for the PVR
The responses on the maximum amount of money procurers would be willing to pay for the PVR are
shown in Table 24.
TABLE 24

Procurers’ opinion on appropriate price for PVR by sector

Sector

n

Smallest Amount Highest Amount Interquartile range
(KES)
(KES)
(KES)

Public

2

200 (US$2)

Donors

2

Private nonprofit

5

Private commercial
All providers
(combined)

Mean (KES)

Median (KES)

255 (US$2.55)

55 (US$0.55)

227 (US$2.27)

227 (US$2.27)

100 (US$1)

500 (US$5)

400 (US$4)

868 (US$8.68)

300 (US$3)

0 (US$0)

850 (US$8.50)

100 (US$1)

270 (US$2.70)

200 (US$2)

5

90 (US$0.9)

3,000 (US$30)

950 (US$4)

697 (US$6.97)

200 (US$2)

16

0 (US$0)

3,000 (US$30)

400 (US$4)

465 (US$4.65)

200 (US$2)
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The mean price for the PVR ranged from KES227 (US$2.27) in the public sector to KES697 (US$6.97) in
the private commercial sector. A comparison of the lowest and highest prices that procurers were willing
to pay for the PVR by sector is made in Figure 8.
Procurers in the private commercial sector were willing to pay the highest maximum price for the PVR.

FIGURE 8 PROCURERS’ WTP MAXIMUM PRICE BY SECTOR
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Assessing Procurers’ Interest in the One-Year CVR
Procurers were asked whether they would be interested in the one-year CVR. Nearly all the procurers
(95%) responded in the affirmative, and cited many reasons why they would be interested in the one- year
CVR (Table 25).
TABLE 25 Procurers’ interest in the one-year CVR
Reason

Frequency

The method will provide an alternative to mothers (and address the pill burden9)

2

If the method is in the country and it is effective, we will of course try it.

3

If women and their partners are willing to use it, then it will widen the options available

3

If there are no complications, then it is a good product

3

We are open to any FP method that comes along as long as it is effective

4

If the method has been recommended by the Pharmacy and Poisons Board we will procure it

1

Total

2

The procurers also pointed out the following issues: information on method effectiveness and side effects
should be shared widely; male involvement will be critical; emphasis needs to be made that the new method
will not prevent HIV; myths need to be addressed about FP methods being inserted into the vagina.

9

A complex medication regimen—daily reminders, schedules, dosage; one that taxes a patient’s adherence.
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Conclusion
New product introduction strategies often suffer from a lack of available market research and rely on
hypothetical approaches to gauge consumer demand. The PVR, as a new product in sub-Saharan Africa,
also faces such a challenge. The Kenyan family planning program is largely a public sector program.
Family planning services and contraceptives are offered free of charge in public sector facilities, and the
government is the major source of contraceptives across the public, private-commercial, and private
nonprofit sectors.
To prepare for and facilitate the PVR’s eventual introduction into Kenya, we undertook this study to
assess “Willingness to Pay,” “Willingness to Provide,” and “Willingness to Procure.” Findings generated on
all three aspects are listed below.


Women seeking family planning services at public, nonprofit, and for-profit facilities are willing to
pay for the PVR if it becomes available. A significant proportion of women who visit the private
commercial sector spend KES50–199 per month on FP services and products. This implies that a
market currently exists for FP products through the private commercial sector channel.



The majority of respondents were willing to pay a price equivalent to a three-month supply of POP
(Microlut) as well as a 10% increment on the price, with some variation across sectors.
Respondents from public sector facilities were more sensitive to marginal price increments than
those who were interviewed at private sector facilities.



Nearly universally, health care providers (based in public, nonprofit, and private commercial
facilities) indicated that the PVR is an important option to include in the choice of methods,
especially in light of the frequent and prolonged stock-outs of Microlut. They are willing to counsel
and provide it to users. Providers in the public and nonprofit sectors suggested a median price of
KES100 (US$1), and those in the private commercial sector proposed a median price of KES200
(US$2).



Procurers are willing to procure the PVR and make it available through their distribution networks
and outlets. They are willing to purchase the PVR at much higher costs than what consumers had
proposed.



All key stakeholders (women, providers, and procurers in public, nonprofit, and for-profit private
sectors) were interested and supportive of the one-year ring. All those interviewed were willing to
pay for the long-acting ring at higher costs than the PVR. The median price for the one-year ring
varied across the sectors—100KES (US$1) in the public sector, 400KES (US$4) in the nonprofit
private sector, and 500KES (US$5) in the private commercial sector.



There is potential for the private sector to play an active role in FP provision that can be utilized
for the introduction of the PVR. This sector can serve the segment of customers that have
expressed higher levels of willingness to pay for the PVR. Social marketing organizations and
commercial players can ease the burden on public health expenditure while tapping into Kenya’s
growing economy, presenting consumers with varying levels of ability to pay for FP products and
services.
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It is important to note that some of the target groups assessed, including a number of the facilities and
health providers in the nonprofit private sector, had small sample sizes compared to public and for-profit
private sector teams. The study highlights the ability of public sector consumers to afford FP products and
the potential for serving them via private sector mechanisms.
In terms of utilization, the results generated will inform and guide next steps about product introduction.
Specifically, the findings of this study will be integrated with results from a market-segmentation exercise
conducted earlier to develop a pricing model for the PVR. The price will reflect not only the COGS and cost
of product introduction (training, educational material, marketing and branding, demand creation) but
also the benefits to the health system (e.g., limited need for infrastructure and equipment, potential for
multiple service outlets and health cadres). The results will also be useful to refine PVR market
segmentation and tailor specific strategies for product introduction, including innovative financing
approaches.
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